Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
Launched by OREGON HEALTH AND SCIENCE UNIVERSITY · Jun 30, 2022
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the use of a tourniquet during ankle fracture surgery affects the pH levels in the muscles and the overall recovery of patients. A tourniquet is a device that temporarily stops blood flow to the area being operated on, and the researchers want to find out if this has any impact on how well patients do after their surgery, including how they feel and how well they can move.
To participate in this study, you need to be an adult between 18 and 89 years old who is having surgery to fix an ankle fracture at OHSU. However, if you have severe infections or serious injuries to other bones, you won’t be eligible. If you join the trial, you can expect to have your muscle pH monitored during and after the surgery, and your recovery will be tracked to see how tourniquet use affects your healing process. This trial is currently recruiting patients of all genders, so if you or someone you know is undergoing this type of surgery, it might be a good opportunity to help advance medical knowledge in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (18 years to 89 years) undergoing surgical ankle fracture fixation at OHSU
- Exclusion Criteria:
- • sepsis
- • other significant long bone or internal injuries (including ipsilateral limb injuries).
About Oregon Health And Science University
Oregon Health and Science University (OHSU) is a leading academic medical center dedicated to advancing health through research, education, and patient care. As a prominent sponsor of clinical trials, OHSU leverages its extensive expertise in various medical fields to facilitate innovative research aimed at improving patient outcomes. The institution is committed to ethical standards and rigorous scientific methodologies, fostering collaborations that enhance the development of new therapies and interventions. With a focus on translating research discoveries into clinical practice, OHSU plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Oregon, United States
Patients applied
Trial Officials
Lara Atwater, MD
Principal Investigator
Oregon Health and Science University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials